Risk prediction for the thrombosis of permanent vascular access

Author:

Staroverov I. N.1ORCID,Noshchenko N. S.1ORCID,Shubin L. B.2ORCID,Lonchakova O. M.1ORCID

Affiliation:

1. State healthcare institution of Yaroslavl region «Regional clinical hospital»; Yaroslavl State Medical University

2. Yaroslavl State Medical University

Abstract

Aim: to improve surgical treatment results in patients with primary permanent vascular access. Materials and methods: the results of the treatment of 168 patients with native arteriovenous radiocephalic fistula were analyzed. The results of treatment within 1 year were tracked According to the observation results, patients were divided into 2 groups: the 1st group — patients who did not develop thrombosis of an arteriovenous fistula for 1 year of hemodialysis, and the 2nd group — patients who had vascular access due to thrombosis during the first year. Results: the factors with the greatest degree of influence on the risk of thrombosis during time periods up to 6 months and from 6 months to 1 year were identified. However, not all of them by their characteristics, satisfied the conditions for constructing a multidimensional logistic regression and a predictive model based on it. On the basis of the identified factors, prognostic models have been established that assess the risk of thrombosis of permanent vascular access at time intervals of up to 6 months and from 6 months to 1 year. Conclusion: the formation of a predictive model considering a variety of factors can give an answer to the risk of thrombosis formation and determine ways to reduce it.

Publisher

Publishing House OKI

Reference11 articles.

1. Tomilina N.A., Andrusev A.M., Peregudova N.G., Shinkarev M.B. Zamestitel'naya terapiya terminal'noi khronicheskoi pochechnoi nedostatochnosti v Rossiiskoi Federatsii v 2010-2015 gg. Otchet po dannym Obshcherossiiskogo Registra zamestitel'noi pochechnoi terapii Rossiiskogo dializnogo obshchestva, Chast' pervaya. Nefrologiya i dializ. 2017. 19(4):1-95. doi: 10.28996/1680-4422-2017-4suppl-1-95 [Tomilina N.A., Andrusev A.M., Peregudova N.G., Shinkarev M.B. Renal replacement therapy for End Stage Renal Disease in Russian Federation, 2010-2015. Russian National Renal Replacement Therapy Registry Report of Russian Public Organization of Nephrologists "Russian Dialysis Society", Part 1. Nephrology and dialysis. 2017. 19(4):1-95. doi: 10.28996/1680-4422-2017-4suppl-1-95]

2. Stetsyuk E.A. Osnovy gemodializa. GEOTAR–MED. – M. : Izd–vo GEOTAR–MED, 2001. – 392s. [Stecyuk E.A. Osnovy gemodializa. GEHOTAR–MED. – M. : Izd–vo GEHOTAR–MED, 2001. – 392s.]

3. Smith GE, Barnes R, Fagan M, Chetter IC. The Impact of Vein Mechanical Compliance on Arteriovenous Fistula Outcomes. Ann Vasc Surg. 2016 Apr;32:9-14. doi: 10.1016/j.avsg.2015.11.002. Epub 2016 Jan 25. PMID: 26820359.

4. Yeh CH, Huang TS, Wang YC, Huang PF, Huang TY, Chen TP, Yin SY, Yu YW. Effects of Antiplatelet Medication on Arteriovenous Fistula Patency After Surgical Thrombectomy. Curr Vasc Pharmacol. 2016;14(4):353-9. doi: 10.2174/1570161114666160229115844. PMID: 26924326.

5. Tanner NC, Da Silva A. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts. Cochrane Database of Systematic Reviews. 2015, Issue 7. Art. No.: CD002786. DOI: 10.1002/14651858.CD002786.pub3. Accessed 22 August 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3